Bill Midgette retired from Porex Corporation in 2016, after serving as the President and CEO for 13 years, and following two successful leveraged buyouts. During his tenure, Porex realized several successful M&A transactions, on both the buying and selling side, on its way to becoming the global leader in advanced porous polymer solutions. Midgette has served as Managing Director for subsidiary companies in Japan, China, Germany, U.K. and Malaysia, as well as holding advisory board positions in industry associations in the U.S. and internationally.
Previously, Midgette spent 18 years with C.R.Bard, Inc., where he held several senior executive positions including as President of Bard International, Inc., Bard Medical, and Bard Japan Ltd. During his tenure, he led the investment in, and development and commercialization of market changing products in the cardiovascular, endovascular and urology markets.
Over his career, Midgette has executed on the development and commercialization of new product technologies, in bioscience, medical and advanced materials markets, through licensing, strategic partnerships, joint ventures, and acquisitions. He is the holder of two patents on commercialized medical device technologies, with a third pending.
Midgette now leads Fairburn Equity partners, advises early stage technology companies, and is on the Board of Carbice Corporation. Bill received a Bachelor of Environmental Studies Degree at the University of Waterloo, about a hundred years ago.